NEW YORK, Sept. 26 – Integrated Genomics of Chicago has licensed three of its microbial genome sequencing technologies to Genencor, the companies announced Tuesday.

Under the terms of the deal Genencor will have a license to use Integrated Genomics’ genome sequence data for Aspergillus niger , the ERGO bioinformatics tools, and Genome Explorer, which allows scientists to analyze regulatory pathways.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.